Treatment for Covid-19 with SARS-CoV-2 neutralizing antibody BRII-196(Ambavirumab) plus BRII-198(Lomisivir): a retrospective cohort study
Monoclonal antibody therapy for Covid-19 springs up all over the world and get some efficiency. This research aims to explore the treating effect of BRII-196(Ambavirumab) plus BRII-198(Lomisivir) on Covid-19.
Source: BMC Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Qin Yalan, Hao Lingfang, Liu Xisong, Liang Run, Zhang Junjing and Zhang ’ An Tags: Research Source Type: research